Tuberculosis (TB)

Key bottlenecks in M/XDR-TB control and patient care

Christopher Alabado receives his daily injection at the International Center for Tuberculosis in Manila, Philippines.
WHO/Dominic Chavez
Christopher Alabado receives his daily injection of capreomycin at the International Center for Tuberculosis in Manila, Philippines.

A number of key bottlenecks, which are common across many affected countries planning and beginning to implement the M/XDR-TB response, will require political decisions within the health system as a whole to overcome. These bottlenecks will be addressed in Beijing as follows:

Related links